S3927751
GSK256066 , 801312-28-7
Synonym(s):
6-({3-[(Dimethylamino)carbonyl]phenyl}sulfonyl)-8-methyl-4-{[3-(methoxy)phenyl]amino}-3-quinolinecarboxamide;6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide;GSK 256066;GSK-256066
CAS NO.：801312-28-7
Empirical Formula: C27H26N4O5S
Molecular Weight: 518.58
MDL number: MFCD18206923
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB779.24 | In Stock |
|
| 25MG | RMB3141.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 791.7±60.0 °C(Predicted) |
| Density | 1.345 |
| storage temp. | Store at -20°C,unstable in solution, ready to use. |
| solubility | insoluble in DMSO; insoluble in EtOH; insoluble in H2O |
| pka | 15.01±0.30(Predicted) |
| form | solid |
| color | Light yellow to yellow |
Description and Uses
Quinoline derivative and a potential selective PDE4 phosphodiesterase inhibitor to treat prophylaxis or treatment of clinical conditions such as inflammatory or allergic diseases.
Safety
| Symbol(GHS) |   GHS08,GHS06 |
| Signal word | Danger |
| Hazard statements | H373-H335-H330 |
| Precautionary statements | P260-P314-P501-P260-P271-P284-P304+P340-P310-P320-P403+P233-P405-P501 |
